Inteliview
Log inSign up
IPO Tracker
S

Seaport Therapeutics, Inc.

Seaport Therapeutics, Inc.

USListed
Valuation$255M
Listed DateApril 10, 2026
Sector--
Exchange--
RELATED IPOS
Picard Medical, Inc.
Picard Medical, Inc.Picard Medical, Inc.US · --
HealthLynked Corp
HealthLynked CorpHealthLynked CorpUS · --
Onconetix, Inc.
Onconetix, Inc.Onconetix, Inc.US · --
A
Aperture ACAperture ACUS · --
Next Bridge Hydrocarbons, Inc.
Next Bridge Hydrocarbons, Inc.Next Bridge Hydrocarbons, Inc.US · --
E
EUPEC International Group LtdEUPEC International Group LtdUS · --
FAQ

When is the Seaport Therapeutics, Inc. IPO expected?

Seaport Therapeutics, Inc. has already gone public. It listed on April 10, 2026.

What is Seaport Therapeutics, Inc.'s valuation?

Seaport Therapeutics, Inc.'s estimated valuation is approximately $255M. The final valuation will depend on IPO pricing and market demand.

Can retail investors participate in the Seaport Therapeutics, Inc. IPO?

U.S. IPOs are typically allocated to institutional investors first. Retail investors can purchase shares on NYSE/NASDAQ after listing. Some brokerages offer IPO access programs for pre-IPO allocation.